Peptide Decoding
New?New to peptides?Start here →
Decoding

GDF-8 (Myostatin)_Dosage, benefits & legal status

Also known as myostatin, growth differentiation factor 8, GDF8

Published August 24, 2026 · Updated October 4, 2026

The protein that limits muscle growth, which is the opposite of what most buyers want.

Muscle growthGrowth factorResearch only
Common vial size1 mg
DoseResearch only
FrequencyVaries
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNo established pattern

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is GDF-8 (Myostatin)?

Plain language first. The technical label stays, but it never stands alone.

Overview

The protein that stops your muscles growing. Selling it next to muscle-building peptides gets the biology exactly backward.

The technical version

Growth differentiation factor 8, a TGF-beta superfamily member signaling through ActRIIB to negatively regulate skeletal muscle mass. Loss-of-function mutations produce documented hypermuscular phenotypes in cattle, canines and humans. The therapeutic targets in this space are myostatin pathway inhibitors, not the ligand itself.

What it's used for

Used as a research reagent. Sold by peptide vendors, where it is frequently confused with the compounds designed to block it.

02

How does GDF-8 (Myostatin) work?

What it does in the body, and where.

Getting this one backward is easy and it is worth being clear.

  1. 01
    Myostatin restrains muscle growth
    It signals through activin receptors to hold muscle building in check. More myostatin activity means less muscle, not more.
  2. 02
    The famous examples are the absence of it
    Belgian Blue cattle, whippets with a particular mutation, and a small number of documented human cases all show large muscles because their myostatin does not work.
  3. 03
    What people actually want is the blocker
    ACE-031, follistatin, bimagrumab, apitegromab and trevogrumab are all attempts to inhibit myostatin or its signaling. Several are in this library. GDF-8 itself is the target rather than the treatment.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Laboratory reagent for studying muscle growth regulationResearch only
  • A target for muscle-wasting drugs, several of which are in this libraryInvestigational

The published record

Research index

5,093

Papers and trials about GDF-8 (Myostatin)

255 papers tagged human · 145 not reviews or lab · 17 clinical trial publications

35 registered trials · 5 with posted results

Furthest stage reached: Phase 2, under way

Compare this against the whole library →

In animals233
In the lab31
Reviews101
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 500 papers and 35 trials indexed in detail.

GDF-8 (Myostatin) vial rendering
Compound field notes

At a glance

Four things to know about GDF-8 (Myostatin)

01

Evidence

Research only

02

Category

Muscle building

03

Common vial

1 mg

04

Half-life

Nothing published in humans

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, varies. No established pattern No range

No published human study establishes a schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing published in humansNo figure

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced dose: 200 mcgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW40 / 100 units
What it costs

GDF-8 (Myostatin) starts at $34.99 across 5 vendors, typically $34.99 – $133.98 per mg.

6 listings, last read Oct 10, 2026. Shipping and card fees are not included.

See all 6 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized GDF-8 (Myostatin) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Any non-laboratory use
  • Pregnancy or breastfeeding

Stop and get help

These are emergencies. Seek care.
  • Any use at all, since this is a research reagent rather than a compound with a human application

Common effects

Expected, and usually mild.
  • No human safety data exists for administering myostatin.
  • No reason exists to administer it, since its biological role is to limit muscle.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is GDF-8 (Myostatin) approved?

And where the numbers on this page come from.

No. GDF-8 (Myostatin) is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    22 September 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 535 records are indexed. Browse the records